Sandra Iurescia earned a Ph.D. in Biochemistry in 1994. She has been a research scientist at the Department of Biology of Roma Tre University since 1997 and then at the Institute of Translational Pharmacology, National Research Council (IFT-CNR) since 2000. Her scientific interest is focused on research and development of new agents (genetic vaccines) for cancer therapy through studies of bioinformatics and immunotherapy. Over the last ten years, her interest has also been directed to the identification and in vitro functional characterization of allelic variants of the promoter region of the human serotonin transporter gene and study of therapeutic protocols in tissue damage and cancer animal models. She is a collaborator in the project Horizon Marie Skłodowska-Curie Actions “Regeneration” and in “Rome Technopole” ECS00000024, PNRR Missione 4 Componente 2 Investimento 1.5 – NextGeneration EU – Spoke n. 5 – Out-reach, public engagement, and long-life learning. She is also the coordinator of the CNR project "Comunicare La Ricerca", and organizer and scientific advisor of numerous workshops and educational activities for communication and scientific dissemination. She is a tutor of graduating students and author of about 36 peer-reviewed scientific papers. She is co-editor of the Springer book “DNA Vaccines” and reviewer for scientific journals. H-index 16.